Getinge (GETI-B.ST) Financial Analysis & Valuation | Quarter Chart

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isola... more
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and ste... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$6.60BExchangeSTO
SectorHealthcareIndustryMedical - Devices
CountrySECEOMattias Perjos
IPO Date2000-01-03CAGR6.27%
Employees11,758Websitewww.getinge.com
Div. Yield0.48%Payout Ratio54%
Buy Back Yield—Total Yield0.48%
GETI-B.ST chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
EV$6.56BP/E22.28Forward P/E16.63PEG0.39
P/S7.76P/B8.58P/CF57.75P/FCF79.89
Sales$3.55BSales 1Y-3.56%Sales 3Y15.06%Sales 5Y15.78%
EPS$1.09EPS 1Y79.8%EPS 3Y24.27%EPS 5Y-31.64%
Sales QoQ12.6%EPS QoQ110.2%Sales QoQ Avg2.34%EPS QoQ Avg29.5%
Gross Margin45.69%Operating Margin12.2%Profit Margin6.92%ROCE9.22%
ROA4%ROE8%Altman Z Score2.89Piotroski Score7
Current Ratio1.35Quick Ratio0.84Cash Ratio0.31Op. CF Ratio0.11
Debt/Equity0.35Debt/Assets0.19Lt Debt/Equity0.29Lt Debt/Cap.0.2
Intrst Cov.6.83Inventory Turnover2.81Asset Turnover0.59Receivables Turnover4.99
Enterprise Value$6.56BP/E Ratio22.28
Forward P/E16.63PEG Ratio0.39
P/S Ratio7.76P/B Ratio8.58
P/CF Ratio57.75P/FCF Ratio79.89
EPS$1.09EPS Growth 1Y79.8%
EPS Growth 3Y24.27%EPS Growth 5Y-31.64%
Revenue Growth 1Y-3.56%Gross Margin0.46%
Operating Margin0.12%Profit Margin0.07%
ROE0.08%ROA0.04%
ROCE0.09%Current Ratio1.35
Quick Ratio0.84Cash Ratio0.31
Debt/Equity0.35Interest Coverage6.83
Altman Z Score2.89Piotroski Score7

View Getinge financial charts →

Getinge (GETI-B.ST) valuation & financials

Getinge (GETI-B.ST) has a market capitalization of 6.60B SEK and trades at a price-to-earnings ratio of 22.3. It operates in the Healthcare sector (Medical - Devices).

Getinge's revenue grew -3.6% over the last year.

Getinge's next earnings report is scheduled for October 21, 2026; analysts estimate EPS of 0.26 SEK. Check the earnings calendar to see all companies reporting this week.

📈 Analysts estimate GETI-B.ST EPS of 0.26 SEK for the upcoming quarter. See Getinge revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Getinge (GETI-B.ST) — frequently asked questions

When does Getinge (GETI-B.ST) report earnings next?

Getinge is expected to report earnings on October 21, 2026. Analysts estimate EPS of 0.26 SEK.

What is Getinge's market cap?

Getinge (GETI-B.ST) has a market capitalization of 6.60B SEK.

What is GETI-B.ST's P/E ratio?

Getinge trades at a price-to-earnings ratio of 22.3, with trailing twelve-month EPS of 1.09 SEK.

How fast is Getinge growing?

Getinge's revenue grew -3.6% over the last year.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)

Getinge revenue & earnings charts →